GEODE CAPITAL MANAGEMENT, LLC
Position in GLUE — Monte Rosa Therapeutics, Inc.
CIK 1214717
BOSTON, MA
Position in GLUE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$45,111,534
+$19,765,177 QoQ
Shares Held
1,864,113
+21.0% QoQ
Ownership
2.19%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 193 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GLUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. GLUE ranks #87 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in GLUE
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $45,111,534 | 1,864,113 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $25,346,357 | 1,540,812 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $18,891,953 | 1,204,844 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $8,533,103 | 1,151,566 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $5,069,961 | 1,124,160 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $4,658,846 | 1,004,062 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $7,194,454 | 1,036,665 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $5,536,851 | 1,044,689 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $3,169,432 | 847,442 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $5,185,507 | 735,533 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $3,885,341 | 687,671 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,101,467 | 647,488 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,200,632 | 613,231 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $4,542,263 | 583,089 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,287,070 | 563,347 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $4,331,015 | 530,112 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,655,289 | 378,003 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $5,014,603 | 357,675 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $4,410,740 | 216,001 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $4,362,045 | 195,783 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||